Heron Therapeutics (HRTX) Raw Materials (2016 - 2026)
Heron Therapeutics (HRTX) reported Raw Materials of $58.09 million for Q2 2026, up 62.2% from $35.82 million a year earlier but down 4.1% from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) Raw Materials (2016 - 2026) Analysis & Trends
At the end of FY2025, Heron Therapeutics posted Raw Materials of $59.25 million, up 200.3% from FY2024.
- Raw Materials has increased for three consecutive years, with a five-year compound annual growth rate of 25.5% (FY2020 to FY2025).
- By year, Raw Materials came in at $19.73 million in FY2024 (+11.8%), $17.64 million in FY2023 (+16.6%), $15.14 million in FY2022 (-28.6%) and $21.19 million in FY2021 (+11.6%).
- Five-year quarterly Raw Materials spans a low of $15.14 million in Q4 2022 and a high of $60.56 million in Q1 2026.
- Year over year, Raw Materials has now increased in each of the last 11 quarters, with growth averaging 83.3% over the last eight quarters.
- The high point for year-over-year Raw Materials in five years was Q1 2026 (growth of 210.4%); the low point was Q1 2023 (a decline of 36.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $60.56 million (Q1 2026), $59.25 million (Q4 2025) and $32.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Heron Therapeutics | 58.85 Mn | -130.71 Mn | 26.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.09 Mn |
| Mar 31, 2026 | 60.56 Mn |
| Dec 31, 2025 | 59.25 Mn |
| Sep 30, 2025 | 32.79 Mn |
| Jun 30, 2025 | 35.82 Mn |
| Mar 31, 2025 | 19.51 Mn |
| Dec 31, 2024 | 19.73 Mn |
| Sep 30, 2024 | 20.82 Mn |
| Jun 30, 2024 | 19.59 Mn |
| Mar 31, 2024 | 18.08 Mn |
| Dec 31, 2023 | 17.64 Mn |
| Sep 30, 2023 | 15.61 Mn |
| Jun 30, 2023 | 18.41 Mn |
| Mar 31, 2023 | 16.41 Mn |
| Dec 31, 2022 | 15.14 Mn |
| Sep 30, 2022 | 18.59 Mn |
| Jun 30, 2022 | 21.83 Mn |
| Mar 31, 2022 | 25.65 Mn |
| Dec 31, 2021 | 21.19 Mn |
| Sep 30, 2021 | 20.98 Mn |
API Access
Heron Therapeutics Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();